The activation of the neutrophil respiratory burst by anti-neutrophil cytoplasm autoantibody (ANCA) from patients with systemic vasculitis requires tyrosine kinases and protein kinase C activation

Clinical and Experimental Immunology

Volumn 118, Issue 1, 1999, Pages 171-179

  Radford, D J ^a   Lord, J M ^a   Savage, C O S ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

ANCA; Neutrophils; PKC; Tyrosine phosphorylation

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; SUPEROXIDE DISMUTASE;

ARTICLE; BLOOD VESSEL WALL; CROSS LINKING; CYTOTOXIC T LYMPHOCYTE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BINDING; RESPIRATORY BURST; SIGNAL TRANSDUCTION; SYSTEMIC VASCULITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CYTOCHALASIN B; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; NEUTROPHILS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; RESPIRATORY BURST; SIGNAL TRANSDUCTION; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULITIS;

EID: 0032881201     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.01043.x     Document Type: Article

References (37)

1. 1 Savage COS, Harper L, Adu D. Primary systemic vasculitis. Lancet 1997; 349:553-8.
2. 2 Savage COS, Pottinger BE, Gaskin G et al. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity towards cultured endothelial cells. Am J Pathol 1992; 141:335-42.
3. 3 Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int 1992; 41:375-83.
4. 4 Falk RJ, Terrell RS, Charles LA et al. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87:4115-9.
5. 5 Charles LA, Falk RJ, Jennette JC. Reactivity of ANCA with mononuclear phagocytes. J Leukocyte Biol 1992; 51:65-8.
6. 6 Lai KN, Lockwood CM. The effect of anti-neutrophil cytoplasm autoantibodies on the signal transduction in human neutrophils. Clin Exp Immunol 1991; 85:396-401.
7. 7 Lai KN, Leung JCK, Rifkin I et al. Effect of anti-neutrophil cytoplasm autoantibodies on the intracellular calcium concentration of human neutrophils. Lab Invest 1994; 70:152-62.
8. 8 Kettritz R, Jennette JC, Falk RJ. Cross-linking of ANCA. antigens stimulates Superoxide release by human neutrophils. J Am Soc Nephrol 1997; 8:386-94.
9. 9 Porges AJ, Redecha PB, Kimberly WT et al. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via FcγRIIa. J Immunol 1994; 153:1271-80.
10. 10 Mulder AHL, Heeringa C, Brouwer E et al. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): an FcγRII-dependent process. Clin Exp Immunol 1994; 98:270-8.
11. 11 Hug H, Sarre TF. Protein kinase C isoenzymes. Divergence in signal transduction? Biochem J 1993; 291:329-43.
12. 12 Dekker LV, Parker PJ. Protein kinase C - a question of specificity. TIBS 1994; 19:73-7.
13. 13 Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein-kinase-C. Science 1992; 258:607-14.
14. 14 Obel D, Rasmussen LH, Christiansen NO. Protein kinase C subtypes in human neutrophils. Scand J Clin Lab Invest 1991; 51:299-302.
15. 15 Majumdar S, Kane LH, Rossi MW et al. Protein kinase C isotypes and signal-transduction in human neutrophils: selective substrate specificity of calcium-dependent β-PKC and novel calcium-independent nPKC. Biochim Biophis Acta 1993; 1176:276-86.
16. 16 Dang P, Hakim J, Perianin A. Immunochemical identification and transloaction of protein kinase C zeta in human neutrophils. FEBS Letts 1994; 349:338-42.
17. 17 Curnutte JT, Erickson RW, Ding J et al. Reciprocal interactions between protein kinase C and components of the NADPH oxidase complex may regulate superoxide production by neutrophils stimulated with phorbol ester. J Biol Chem 1994; 269:10813-9.
18. 18 Ptasznik A, Prossnitz ER, Yoshikawa D et al. A tyrosine kinase signalling pathway accounts for the majority of phosphatidylinositol 3,4,5-trisphosphate formation in chemoattractant-stimulated human neutrophils. J Biol Chem 1996; 271:25204-7.
19. 19 Toothill VJ, Van-Mourik JA, Niewenhuis HK et al. Characterization of the enhanced adhesion of neutrophil leukocytes to thrombin-stimulated endothelial cells. J Immunol 1990; 145:283-91.
20. 20 Brooks CJ, King WJ, Radford DJ et al. IL-1β production by human polymorphonuclear leukocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis. Clin Exp Immunol 1996; 106:273-9.
21. 21 Mayo LA, Curnutte JT. Kinetic microplate assay for Superoxide production by neutrophils and other phagocytic cells. Methods Enzymol 1990; 186:567-75.
22. 22 Herbert JM, Augereau JM, Gleye J et al. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Comm 1990; 172:993-9.
23. 23 Toullec D, Pianetti P, Coste H et al. The bisindolylmaleimide GF-109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991; 266:15771-81.
24. 24 Martiny-Baron G, Kazanietz MG, Mischak H et al. Selective inhibition of protein kinase C isoenzymes by the indolocarbazole Go6976. J Biol Chem 1993; 268:9194-7.
25. 25 Liang L, Huang C. Tyrosine phosphorylation induced by cross-linking of Fcγ-receptor type II in human neutrophils. Biochem J 1995; 306:489-95.
26. 26 Cockwell P, Brooks CJ, Adu D et al. In vitro and in situ production of IL-8 in ANCA-associated vasculitis. Kidney Int 1997; 52:272-3.
27. 27 Reumaux D, Vossebeld PJM, Roos D et al. Effect of tumor necrosis factor-induced integrin activation on Fcγ receptor II-mediated signal transduction: relevance for activation of neutrophils by anti proteinase 3 or anti-myeloperoxidase antibodies. Blood 1995; 86:3189-95.
28. 28 Wenzel-Seifert K, Schachtele C, Seifert R. N-protein kinase C isoenzymes may be involved in the regulation of various neutrophil functions. Biochem Biophys Res Comm 1994; 200:1536-43.
29. 29 Huang CK, Laramee GR, Casnellie JE. Chemotactic factor induced tyrosine phosphorylation of membrane associated proteins in rabbit peritoneal neutrophils. Biochem Biophys Res Comm 1988; 151:794-801.
30. 30 Gomez-Cambronero J, Huang CK, Bonak VA et al. Tyrosine phosphorylation in human neutrophil. Biochem Biophys Res Comm 1989; 162:1478-85.
31. 31 Naccache PH, Gilbert C, Caon AC et al. Selective inhibition of human neutrophil functional responsiveness by erbstatin, an inhibitor of tyrosine protein-kinase. Blood 1990; 76:2098-104.
32. 32 Kusunoki T, Higashi H, Hosoi S et al. Tyrosine phosphorylation and its possible role in superoxide production by human neutrophils stimulated with FMLP and IgG. Biochem Biophys Res Commun 1992; 183:789-96.
33. 33 Rollet E, Caon AC, Roberge CJ et al. Tyrosine phosphorylation in activated human neutrophils. Comparison of the effects of different classes of agonists and identification of the signaling pathways involved. J Immunol 1994; 153:353-63.
34. 34 Cerna H, Fiala B, Han K et al. Antiphlogistics in peridontistry. Acta Univ Palacki Olomue Fac Med (Czechoslovakia) 1989; 123:293-302.
35. 35 Ishii H, Jirousek MR, Koya D et al. Amelioration of vascular dysfunction in diabetic rats by an oral PKB β inhibitor. Science 1996; 272:728-31.
36. 36 Jacobson PB, Kuchera SL, Metz A et al. Anti-inflammatory properties of Go 6850: a selective inhibitor of protein kinase C. J Pharm Exp Therapeut 1995; 275:995-1002.
37. 37 Kuchera S, Barth H, Jacobson P et al. Anti-inflammatory properties of the protein kinase C inhibitor3-[l-[3-(dimethylamino) propyl]-1H-indol-3-yl]-4-(1H-inol-3-yl)-1H-pyrrole-2,5-dione monochloride (GF109203X) in the PMA-mouse ear edema model. Agents Actions 1993; 39;C169-C73.